Detailed information for compound 1050479

Basic information

Technical information
  • TDR Targets ID: 1050479
  • Name: N-(4-diethylaminophenyl)-2-nitrobenzamide
  • MW: 313.351 | Formula: C17H19N3O3
  • H donors: 1 H acceptors: 3 LogP: 3.44 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(c1ccc(cc1)NC(=O)c1ccccc1[N+](=O)[O-])CC
  • InChi: 1S/C17H19N3O3/c1-3-19(4-2)14-11-9-13(10-12-14)18-17(21)15-7-5-6-8-16(15)20(22)23/h5-12H,3-4H2,1-2H3,(H,18,21)
  • InChiKey: ILACFEJISPLWOY-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(4-diethylaminophenyl)-2-nitro-benzamide
  • BIM-0033840.P001
  • Oprea1_003763
  • CBMicro_033668
  • Oprea1_547325
  • ZINC00038831
  • AN-329/12072549
  • ARONIS021166
  • ST055105

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Toxoplasma gondii enoyl-acyl carrier reductase ENR Get druggable targets OG5_130466 All targets in OG5_130466
Wolbachia endosymbiont of Brugia malayi enoyl-ACP reductase Get druggable targets OG5_130466 All targets in OG5_130466
Plasmodium falciparum enoyl-acyl carrier reductase Get druggable targets OG5_130466 All targets in OG5_130466
Neospora caninum enoyl-acyl carrier reductase, putative Get druggable targets OG5_130466 All targets in OG5_130466
Trichomonas vaginalis hypothetical protein Get druggable targets OG5_130466 All targets in OG5_130466
Plasmodium knowlesi enoyl-acyl carrier reductase, putative Get druggable targets OG5_130466 All targets in OG5_130466
Plasmodium vivax enoyl-acyl carrier protein reductase Get druggable targets OG5_130466 All targets in OG5_130466
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) Get druggable targets OG5_130466 All targets in OG5_130466
Plasmodium berghei enoyl-acyl carrier reductase Get druggable targets OG5_130466 All targets in OG5_130466
Plasmodium yoelii enoyl-acyl carrier reductase Get druggable targets OG5_130466 All targets in OG5_130466
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase Get druggable targets OG5_130466 All targets in OG5_130466
Chlamydia trachomatis enoyl-acyl-carrier protein reductase Get druggable targets OG5_130466 All targets in OG5_130466
Mycobacterium leprae NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) Get druggable targets OG5_130466 All targets in OG5_130466

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi oxidoreductase, short chain dehydrogenase/reductase family protein 0.0015 0.0028 1
Echinococcus granulosus 3 oxoacyl acyl carrier protein reductase 0.0015 0.0028 0.0028
Leishmania major 3-oxoacyl-ACP reductase, putative 0.0015 0.0028 0.5
Trypanosoma brucei oxidoreductase-like protein 0.0015 0.0028 0.5
Leishmania major dehydrogenase/oxidoreductase-like protein 0.0015 0.0028 0.5
Mycobacterium leprae NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) 0.0223 0.3215 1
Loa Loa (eye worm) hypothetical protein 0.0015 0.0028 1
Wolbachia endosymbiont of Brugia malayi enoyl-ACP reductase 0.0223 0.3215 1
Schistosoma mansoni 3-oxoacyl-[ACP] reductase 0.0015 0.0028 0.0029
Trypanosoma cruzi oxidoreductase-like protein, putative 0.0015 0.0028 0.5
Loa Loa (eye worm) oxidoreductase 0.0015 0.0028 1
Onchocerca volvulus 0.0015 0.0028 0.5
Trichomonas vaginalis hypothetical protein 0.0223 0.3215 0.5
Echinococcus multilocularis ankyrin repeat protein 0.0654 0.9796 0.9796
Echinococcus multilocularis transient receptor potential cation channel 0.0667 1 1
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) 0.0223 0.3215 1
Leishmania major dehydrogenase/oxidoreductase-like protein 0.0015 0.0028 0.5
Loa Loa (eye worm) 3-hydroxyacyl-CoA dehydrogenase type II 0.0015 0.0028 1
Echinococcus multilocularis 3 oxoacyl acyl carrier protein reductase 0.0015 0.0028 0.0028
Toxoplasma gondii enoyl-acyl carrier reductase ENR 0.0223 0.3215 1
Chlamydia trachomatis enoyl-acyl-carrier protein reductase 0.0223 0.3215 1
Schistosoma mansoni transient receptor potential cation channel subfamily A member 0.0654 0.9796 1
Schistosoma mansoni dihydropteridine reductase 0.0015 0.0028 0.0029
Trypanosoma brucei beta-ketoacyl-ACP reductase 0.0015 0.0028 0.5
Echinococcus granulosus ankyrin repeat protein 0.0654 0.9796 0.9796
Trypanosoma brucei pteridine reductase 1 0.0015 0.0028 0.5
Plasmodium vivax enoyl-acyl carrier protein reductase 0.0223 0.3215 1
Brugia malayi oxidoreductase, short chain dehydrogenase/reductase family protein 0.0015 0.0028 1
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase 0.0223 0.3215 1
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0015 0.0028 0.5
Onchocerca volvulus 0.0015 0.0028 0.5
Entamoeba histolytica 3-oxoacyl-(acyl-carrier protein) reductase, putative 0.0015 0.0028 0.5
Leishmania major oxidoreductase-like protein 0.0015 0.0028 0.5
Loa Loa (eye worm) retinol dehydrogenase 12 0.0015 0.0028 1
Leishmania major pteridine reductase 1 0.0015 0.0028 0.5
Plasmodium falciparum enoyl-acyl carrier reductase 0.0223 0.3215 1
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0015 0.0028 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 4.37 uM Inhibition of Mycobacterium tuberculosis InhA ChEMBL. 19428156

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.